Our search works best when asked a question.
|
Please review the policies that apply to all areas of this site. Your continued use of the site means that you accept these policies.
We subscribe to the HONcode principles.
 Verify here.
|
|
|
|
Health Alerts
|
|
Baxter's Multiple-dose Vial Heparin |
February 11, 2008 |
The U.S. Food and Drug Administration announced today that Baxter Healthcare Corporation has temporarily stopped manufacturing multiple-dose vials of the injectable blood-thinning drug heparin due to reports of serious allergic reactions and hypotension (low blood pressure) in patients who receive high "bolus" doses of the drug. Serious reactions to the drug have included difficulty breathing, nausea, vomiting, excessive sweating, and rapidly falling blood pressure that can lead to life-threatening shock. full story »
|
Adverse Reactions Linked to Botox Use |
February 8, 2008 |
The U.S. Food and Drug Administration today notified the public that Botox and Botox Cosmetic (Botulinum toxin Type A) and Myobloc (Botulinum toxin Type B) have been linked in some cases to adverse reactions, including respiratory failure and death, following treatment of a variety of conditions using a wide range of doses. full story»
|
|
|
Email This Page
Printer Friendly Page
